These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 5344814)

  • 1. [Pulmonary volumetric changes caused by N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Brignani F; Cavalli A; Fabbri M; Melica A
    Minerva Med; 1969 Sep; 60(75):3545-8. PubMed ID: 5344814
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinico-experimental studies of the mucolytic action of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride, in oral and parenteral administration, in acute and chronic pneumopathies].
    Carnimeo N; Fino E; Maiorano V; Marzullo F
    Minerva Med; 1969 Sep; 60(76):3557-64. PubMed ID: 5823750
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the treatment of some forms of acute and chronic bronchial diseases with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Trombini V
    Minerva Med; 1969 Sep; 60(76):3600-3. PubMed ID: 5823757
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical experience with a new preparation with bronchosecretolytic action: Bisolvon or N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride].
    Ercillo L; Mollica G
    Minerva Med; 1969 Sep; 60(76):3604-6. PubMed ID: 5823758
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride in oral adminstration on bronchial secretions; cytological findings].
    Lenzini L; Barnabè R
    Minerva Med; 1969 Sep; 60(76):3580-2. PubMed ID: 5823754
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride on expectoration, respiratory function, hepatic and cardiac function of subjects with chronic bronchopneumopathies].
    Scarpa GL; Malavasi A; Dimich D; Giraudi D
    Minerva Med; 1969 Sep; 60(76):3594-9. PubMed ID: 5823756
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical considerations on a recent preparation with bronchial secretolytic action].
    Santilli E; Castellana G
    Minerva Med; 1969 Sep; 60(76):3583-93. PubMed ID: 5823755
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical trial of a new substance with secretolytic action].
    Bontà L
    Minerva Med; 1969 Sep; 60(75):3525-44. PubMed ID: 5344813
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical experience with a new secretolytic drug.
    Villa R; Orlandini GC
    Minerva Med; 1969 Sep; 60(76):3607-10. PubMed ID: 5823759
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical trial of N-cyclohexyl-N-methyl(-2-amino-3,5-dibromobenzyl)-ammonium chloride associated with antibiotics in therapy of chronic bronchopneumopathies].
    Quilici G; Da Porto R
    Clin Ter; 1970 Sep; 54(6):495-517. PubMed ID: 5527647
    [No Abstract]   [Full Text] [Related]  

  • 11. [Apropos of 27 patients treated with bisolvomycin].
    Breuil K
    Bord Med; 1971 Sep; 4(9):2469-70. PubMed ID: 5123583
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical trial of bromhexine.
    Thompson KJ; Reeve J
    N Z Med J; 1972 Aug; 76(483):73-6. PubMed ID: 4264310
    [No Abstract]   [Full Text] [Related]  

  • 13. [Contribution to the treatment of serous or purulent bronchial hypersecretion in acute and chronic bronchopneumopathies].
    Baracco F; Repetto E; Giordano L
    Minerva Med; 1969 Sep; 60(75):3509-13. PubMed ID: 5344811
    [No Abstract]   [Full Text] [Related]  

  • 14. [A derivative of benzyl-amine in the therapy of respiratory diseases in children].
    Gambi R; Ongaro F; Paoli R; Russo U
    Minerva Med; 1969 Sep; 60(76):3575-9. PubMed ID: 5823753
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bisolvon in pneumological practice].
    Ollagnier C; Vallon MC
    Lyon Med; 1969 Dec; 222(46):1233-5. PubMed ID: 4905093
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of therapeutic effect of 2 application forms of a combination of N-cyclohexyl-N-methyl-(2-amino-3,5-dibrombenzyl)-ammonium-chloride and sulfanilamidopyrimidine. A widespread mutual test].
    Oligschläger G
    Arzneimittelforschung; 1969 Oct; 19(10):1710-7. PubMed ID: 5395373
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical observations on the effects of the association of N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium chloride and oxytetracycline in acute and chronic bronchopathies].
    Bini P; Romagnoli E
    Clin Ter; 1970 Dec; 55(5):433-59. PubMed ID: 5516108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bisolvon in the treatment of the tracheo-bronchial secretory syndrome of the laryngectomized].
    Ameli M
    Minerva Med; 1969 Sep; 60(75):3503-8. PubMed ID: 5344810
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical, respiratory functional, bacteriological and immunological observations on the use of Bisolvon].
    Bernardini V; Camerota G; Baronti A; Curti PC
    Minerva Med; 1969 Sep; 60(75):3514-20. PubMed ID: 4186563
    [No Abstract]   [Full Text] [Related]  

  • 20. A new mucolytic, bromhexine ("bisolvon"). A double-blind study.
    Bateman PP
    Med J Aust; 1971 May; 1(18):963-5. PubMed ID: 4930812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.